(Q37942791)

25 August 2017

1 reference

title

Idiopathic pulmonary fibrosis: treatment update (English)

1 reference

idiopathic pulmonary fibrosis

25 August 2017

1 reference

1 reference

Oisin J O'Connell

1

1 reference

25 August 2017

Marcus P Kennedy

series ordinal

2

1 reference

25 August 2017

Michael T Henry

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

28

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

986-999

1 reference

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

The rising incidence of idiopathic pulmonary fibrosis in the U.K

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Fleischner Society: glossary of terms for thoracic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Acute exacerbations of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

High-dose acetylcysteine in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Pirfenidone in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

TPMT testing in rheumatology: any better than routine monitoring?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Antioxidant therapy for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Sildenafil in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Anticoagulant therapy for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Idiopathic pulmonary fibrosis and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Incremental value of PET/CT Over CT for mediastinal nodal staging of non-small cell lung cancer: Comparison between patients with and without idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

CT-guided Transthoracic Needle Aspiration Biopsy of Pulmonary Nodules: Needle Size and Pneumothorax Rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

Percutaneous lung biopsies: a survey of UK practice based on 5444 biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0066-5

10.1007/S12325-011-0066-5

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference